Table 3.
The Graphene Oxide and Their Composite to Microenvironment in Cell Culture or Organoid Culture
| Materials | Cell Line/ Primary Cell In Vitro | Applications | Cell Characteristics | Ref. |
|---|---|---|---|---|
| PANI–GO | SH-SY5Y, cortical neuronal cell | Tissue engineering and regeneration | Neurospheres formation. | [59] |
| CMCs-GelMa-GO-PLGA | HUVECs | Tissue engineering and regeneration | Tubule-like blood vessel network formation. | [60] |
| Ce-GO | HUVECs, HMSCs | Tissue engineering and regeneration | Spheroid formation. | [61] |
| EU/GL/TiO2 | mESCs | Tissue engineering and regeneration | Embryoid bodies formation and colonies ESCs structures. | [62] |
| CH-GO | SH-SY5Y | Tissue engineering and regeneration | Cell phenotype like epithelial, cell growth is spread and elongated uniformly on the cell surface. | [64] |
| rGOM | ARPE-19, HCE-T | Tissue engineering and regeneration | Cells formed “polygonal”. | [65] |
| rGO-PCL | ADSCs | Tissue engineering and regeneration | Elongated spindle – like morphology. | [66] |
| adECM-PDA-rGO | NE-4C neuronal cell line | Tissue engineering and regeneration | Neuron like structures formation. | [67] |
| rGO-Mxene | MSU-1.1, HeLa, SH-SY5Y | Tissue engineering and regeneration | Maintaining cell phenotype. | [68] |
| SPI-SH-GA@PGO | HUVECs | Skin therapy | Tubule-like blood vessel network formation. | [70] |
| GO/rGO | MSCs | Therapeutic agents | Cells elongated with large nucleus (type of MSCs) and maintaining cell phenotype. | [84] |
| PEG-GO | MDA-MB-231, MDA-MB-436, MCF-10A | Cancer Therapy | Breast cancer cells metastated. | [86] |